Home / Indicator library / Biotechnology and Medical Care / G&E (4911) overview
G&E (4911) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for G&E, on one pageG&E (4911) snapshot, key figures
G&E (4911): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→4911: common questions
What is 4911's P/E ratio?
4911 traded at a price-to-earnings ratio of 15.87x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 4911's dividend yield?
4911's cash dividend yield was 6.73% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 4911's revenue growing?
4911 reported -57.6% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 4911's price / earnings high or low right now?
4911's price / earnings is 15.87x, which is below its one-year median of 18.64x and sits at the 7th percentile of the 15.00–24.90x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 4911's dividend yield high or low right now?
4911's dividend yield is 6.73%, which is above its one-year median of 3.77% and sits at the 100th percentile of the 2.85–6.71% range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.